Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (281-290 of 494) with videos related to

Pageof 50
Sort By:
Cancer Research|April 30, 2011
MMSET is highly expressed and associated with aggressiveness in neuroblastomaHeidi Rye Hudlebusch, Julie Skotte, Eric Santoni-Rugiu, et al.
Breast Cancer Research and Treatment|November 30, 2004
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancerGilbert Spizzo, Philip Went, Stephan Dirnhofer, et al.
Genes, Chromosomes & Cancer|January 10, 2019
5q21 deletion is often heterogeneous in prostate cancerMartina Kluth, Zaid Al Kilani, Cansu Özden, et al.
World Journal of Surgical Oncology|June 15, 2020
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinomaTill Eichenauer, Navid Shadanpour, Martina Kluth, et al.
Cancers|April 14, 2025
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal AdenocarcinomasNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Cell Reports|July 29, 2014
Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancerDavid Brocks, Yassen Assenov, Sarah Minner, et al.
Genes, Chromosomes & Cancer|June 21, 2018
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancerMartina Kluth, Sekander Scherzai, Franziska Büschek, et al.
Pathology International|August 11, 2020
High B7-H3 expression is linked to increased risk of prostate cancer progressionSarah Bonk, Pinar Tasdelen, Martina Kluth, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapySarah Minner, Malaika Enodien, Hüseyin Sirma, et al.
Pageof 50

Showing results (281-290 of 494) with videos related to

Sort By:
Pageof 50
Cancer Research|April 30, 2011
MMSET is highly expressed and associated with aggressiveness in neuroblastomaHeidi Rye Hudlebusch, Julie Skotte, Eric Santoni-Rugiu, et al.
Breast Cancer Research and Treatment|November 30, 2004
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancerGilbert Spizzo, Philip Went, Stephan Dirnhofer, et al.
Genes, Chromosomes & Cancer|January 10, 2019
5q21 deletion is often heterogeneous in prostate cancerMartina Kluth, Zaid Al Kilani, Cansu Özden, et al.
World Journal of Surgical Oncology|June 15, 2020
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinomaTill Eichenauer, Navid Shadanpour, Martina Kluth, et al.
Cancers|April 14, 2025
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal AdenocarcinomasNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Cell Reports|July 29, 2014
Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancerDavid Brocks, Yassen Assenov, Sarah Minner, et al.
Genes, Chromosomes & Cancer|June 21, 2018
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancerMartina Kluth, Sekander Scherzai, Franziska Büschek, et al.
Pathology International|August 11, 2020
High B7-H3 expression is linked to increased risk of prostate cancer progressionSarah Bonk, Pinar Tasdelen, Martina Kluth, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapySarah Minner, Malaika Enodien, Hüseyin Sirma, et al.
Pageof 50